Wells Fargo’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21
Closed -$49 7382
2025
Q4
$49 Hold
21
﹤0.01% 6527
2025
Q3
$18 Hold
21
﹤0.01% 6725
2025
Q2
$14 Hold
21
﹤0.01% 6864
2025
Q1
$14 Hold
21
﹤0.01% 6728
2024
Q4
$35 Hold
21
﹤0.01% 6570
2024
Q3
$75 Hold
21
﹤0.01% 6308
2024
Q2
$95 Sell
21
-6
-22% -$33 ﹤0.01% 6255
2024
Q1
$164 Buy
27
+1
+4% +$7 ﹤0.01% 6542
2023
Q4
$226 Buy
26
+2
+8% +$17 ﹤0.01% 6578
2023
Q3
$213 Sell
24
-1
-4% -$18 ﹤0.01% 6565
2023
Q2
$633 Buy
25
+3
+14% +$75 ﹤0.01% 6435
2023
Q1
$1.18K Hold
22
﹤0.01% 6333
2022
Q4
$1.74K Hold
22
﹤0.01% 6043
2022
Q3
$2K Hold
22
﹤0.01% 6176
2022
Q2
$7K Hold
22
﹤0.01% 5898
2022
Q1
$17K Buy
22
+14
+175% +$11.3K ﹤0.01% 6081
2021
Q4
$8K Hold
8
﹤0.01% 6620
2021
Q3
$16K Buy
+8
New +$17.7K ﹤0.01% 6046
2021
Q2
Hold
0
6711
2021
Q1
Hold
0
7240
2020
Q4
Hold
0
6858
2020
Q3
Hold
0
6730
2020
Q2
Hold
0
6669
2020
Q1
Hold
0
6625
2019
Q4
Hold
0
6626
2019
Q3
Hold
0
6609
2019
Q2
Hold
0
6177
2019
Q1
Hold
0
5814
2018
Q4
Hold
0
6153
2018
Q3
Hold
0
6067
2018
Q2
Hold
0
6006
2018
Q1
Hold
0
5929
2017
Q4
Hold
0
5889
2017
Q3
Hold
0
5924
2017
Q2
Hold
0
5511
2017
Q1
Hold
0
5613
2016
Q4
Hold
0
5629
2016
Q3
Hold
0
5566
2016
Q2
Hold
0
5482
2016
Q1
Hold
0
4986
2015
Q4
Hold
0
4836
2015
Q3
Hold
0
4708
2015
Q2
Hold
0
4538
2015
Q1
Hold
0
4616
2014
Q4
Hold
0
4350
2014
Q3
Hold
0
4206
2014
Q2
Hold
0
4559
2014
Q1
Hold
0
4452
2013
Q4
Hold
0
4899
2013
Q3
Hold
0
4873

Other funds holding PALI

Wells Fargo's PALI Position: Q1 2026 in Review

Wells Fargo sold out of Palisade Bio (PALI) in Q1 2026, closing a stake of 21 shares — an estimated $49 sold.

Wells Fargo first reported a position in PALI in Q3 2021 and held it in 18 quarters. The position peaked at $17K in Q1 2022. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Wells Fargo reported no remaining Palisade Bio position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 21 Palisade Bio shares in Q1 2026, an estimated $49.
  • Wells Fargo first reported a position in Palisade Bio in Q3 2021 and held it in 18 quarters.
  • Wells Fargo's Palisade Bio position peaked at $17K in Q1 2022.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.